NasdaqGS - Nasdaq Real Time Price USD

DexCom, Inc. (DXCM)

130.71 -3.59 (-2.67%)
At close: April 19 at 4:00 PM EDT
129.54 -1.17 (-0.90%)
After hours: April 19 at 7:08 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
3,622,300.00
3,622,300.00
2,909,800.00
2,448,500.00
1,926,700.00
Cost of Revenue
1,333,400.00
1,333,400.00
1,026,700.00
768,000.00
646,600.00
Gross Profit
2,288,900.00
2,288,900.00
1,883,100.00
1,680,500.00
1,280,100.00
Operating Expense
1,691,200.00
1,691,200.00
1,491,900.00
1,414,700.00
980,600.00
Operating Income
597,700.00
597,700.00
391,200.00
265,800.00
299,500.00
Net Non Operating Interest Income Expense
114,700.00
114,700.00
5,200.00
-17,100.00
-68,600.00
Other Income Expense
-2,000.00
-2,000.00
-5,600.00
8,100.00
-5,900.00
Pretax Income
710,400.00
710,400.00
390,800.00
256,800.00
225,000.00
Tax Provision
168,900.00
168,900.00
49,600.00
39,900.00
-268,600.00
Net Income Common Stockholders
541,500.00
541,500.00
341,200.00
216,900.00
493,600.00
Average Dilution Earnings
12,600.00
12,600.00
11,000.00
11,400.00
--
Diluted NI Available to Com Stockholders
554,100.00
554,100.00
352,200.00
228,300.00
493,600.00
Basic EPS
0.98
1.40
0.88
0.56
1.31
Diluted EPS
0.91
1.30
0.82
0.53
1.26
Basic Average Shares
386,625.00
386,000.00
389,400.00
386,900.00
377,600.00
Diluted Average Shares
427,725.00
425,500.00
427,500.00
428,800.00
390,000.00
Total Operating Income as Reported
597,700.00
597,700.00
391,200.00
265,800.00
299,500.00
Total Expenses
3,024,600.00
3,024,600.00
2,518,600.00
2,182,700.00
1,627,200.00
Net Income from Continuing & Discontinued Operation
541,500.00
541,500.00
341,200.00
216,900.00
493,600.00
Normalized Income
541,500.00
541,500.00
341,200.00
216,960.10
497,907.00
Interest Income
135,000.00
135,000.00
23,800.00
1,700.00
16,100.00
Interest Expense
20,300.00
20,300.00
18,600.00
18,800.00
84,700.00
Net Interest Income
114,700.00
114,700.00
5,200.00
-17,100.00
-68,600.00
EBIT
730,700.00
730,700.00
409,400.00
275,600.00
309,700.00
EBITDA
916,700.00
916,700.00
565,300.00
377,600.00
376,800.00
Reconciled Cost of Revenue
1,333,400.00
1,333,400.00
1,026,700.00
768,000.00
646,600.00
Reconciled Depreciation
186,000.00
186,000.00
155,900.00
102,000.00
67,100.00
Net Income from Continuing Operation Net Minority Interest
541,500.00
541,500.00
341,200.00
216,900.00
493,600.00
Total Unusual Items Excluding Goodwill
--
--
--
-100.00
-5,900.00
Total Unusual Items
--
--
--
-100.00
-5,900.00
Normalized EBITDA
916,700.00
916,700.00
565,300.00
377,700.00
382,700.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
--
--
--
-39.90
-1,593.00
12/31/2020 - 4/14/2005
Yahoo Finance Plus Essential access required. Unlock Access

Related Tickers

PODD Insulet Corporation
166.25
+0.92%
 
TNDM Tandem Diabetes Care, Inc.
30.43
-1.62%
 
ALGN Align Technology, Inc.
298.98
-0.78%
 
EW Edwards Lifesciences Corporation
85.94
-0.59%
 
BSX Boston Scientific Corporation
67.33
-0.13%
 
SWAV Shockwave Medical, Inc.
329.00
+0.45%
 
MDT Medtronic plc
79.48
+0.37%
 
ABT Abbott Laboratories
107.28
+1.91%
 
SYK Stryker Corporation
325.43
-0.62%
 
SENS Senseonics Holdings, Inc.
0.3992
-4.04%